News
Listening, learning, leading: Dal Medicine's new dean shares his vision
As he begins his term as dean, Dr. Saleem Razack discusses social accountability, medical education, and his vision for strengthening health care across the Maritimes and beyond. Read more.
Featured News
Wednesday, August 19, 2026
Faculty member Barb Hamilton-Hinch, Dallaire Institute ED Shelly Whitman, and several Dal alumni are among this year’s appointees to the Order of Nova Scotia, honouring significant contributions to the province.
Monday, August 24, 2026
A new lab opened at Dalhousie this summer represents a major leap forward for simulation-based health education in Atlantic Canada, offering students access to more advanced training that will prepare them for complex-care situations.
Wednesday, July 29, 2026
From anatomy education to flexible learning and graduate mentorship, this year’s recipients are shaping how students learn, connect, and succeed.
Archives - News
Thursday, July 6, 2023
A governance expert, a labour leader, a refugee lawyer, a provincial court judge, a distinguished health professor, a medical researcher, and an ocean engineer are the latest Dal alumni to receive Canada's highest civilian honour.
Wednesday, July 5, 2023
Hollo Medical co-founder David Hodgson's victory brings added recognition to the startup's key innovation — a unique pocket-size asthma inhaler chamber — and provides a huge boost to the company's goal of making it accessible as quickly as possible.
Wednesday, June 28, 2023
One of Nova Scotia’s most prominent community and business leaders, Rustum Southwell — best known as founding CEO of the renowned Black Business Initiative — is set to take on the mantle of Dalhousie University's top ceremonial role. For Southwell, it represents another chapter in a legacy of lifting people up to grow, thrive and succeed.
Wednesday, June 28, 2023
Now ranked at 298 globally, Dalhousie maintained twelfth place among Canadian universities and remains the top-ranked university in Atlantic Canada.
Tuesday, June 27, 2023
The federal government’s proposed Agile Licensing drug approval regulations mean Canada will have less information about the risks of new medicines, and higher costs.